{"prompt": "['Improving Outcomes for Younger Breast Cancer Survivors: A Phase III', 'Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer', 'Survivors', 'NCT03025139', 'Revised Protocol June 22, 2020', 'The Pathways to Wellness (PTW) Study', 'Protocol Chair', 'Patricia A. Ganz, MD-Medical Oncology', 'UCLA Jonsson Comprehensive Cancer Center', '650 Charles Young Dr. South, Room A2-125 CHS', 'Phone: 310-206-1404', 'Fax: 310-206-3566', 'Email: pganz@mednet.ucla.edu', 'Co-Investigators', 'UCLA', 'Julienne Bower, PhD-Psychology', 'Catherine Crespi, PhD- Biostatistics', 'DFCI', 'Ann Partridge, MD, MPH-Medical Oncology', 'Hadine Joffe, MD, MSc-Psychiatry', 'JHU', 'Antonio Wolff, MD-Medical Oncology', 'Katherine Smith, PhD- Behavioral Science', 'Elissa Thorner, MHS-Health Communication', 'Coordinating Center', 'UCLA Jonsson Comprehensive Cancer Center', 'Protocol Coordinator:', 'Barbara Kahn-Mills, BA', 'Phone: 310-825-2520', 'bkahnmills@mednet.ucla.edu', 'Study Data Manager:', 'Laura Petersen, MS', 'Phone: 310-794-7591', 'Petersen@ucla.edu']['Improving Outcomes for Younger Breast Cancer Survivors: A Phase III Randomized Trial', 'Targeting Behavioral Symptoms in Younger Breast Cancer Survivors', '- Protocol Revision Record -', 'Original Protocol:', 'Final Protocol for Activation, August 25, 2016', 'Protocol edits:', 'Minor technical changes in procedures, instruments, December 19, 2016 and January 23, 2017', 'before activation/enrollment', 'Minor eligibility modification and technical changes, before enrollment, June 15, 2017', 'Change in age eligibility based on DSMB meeting, February 2, 2018', 'Sample size re-estimation and change in PHQ-8 eligibility, May 2019 in consultation with NCI', 'Modifications due to the COVID-19 pandemic, April 10, 2020 and June 22, 2020', 'TABLE OF REVISIONS AND MODIFICATIONS', 'DATE', 'NATURE OF CHANGE', 'SECTION', 'December 19, 2016', 'Intervention training information removed', '6.1', 'from protocol and placed in Appendix B', 'Change in some secondary outcome', '9.2, 9.3, 9.4, Table Summary of', 'measures to reduce respondent burden and', 'Questionnaire Measures', 'measure relevant concepts omitted', 'Change in gene expression measurement', '10.3.1', 'platform', 'Shipping of specimens to UCLA', '11', 'periodically during study', 'New Appendix B describing training for', 'Old appendix B now labeled C, and Old', 'instructors in both intervention conditions', 'appendix C now labeled D', 'Omit section on survivor education group', 'Appendix D deleted pages 50, 51', 'formation and organization; now in', 'training manual', 'January 23, 2017', 'Change from 3 to 2 booster sessions for', '6.2.4', 'mindfulness intervention', 'Added the Social Provisions Attachment', '9.2', 'Scale', 'Further refinement training plan for', 'Appendix B', 'intervention instructors', 'June 15, 2017', 'Added current pregnancy as a study', '4.2.5', 'exclusion', 'Modification to duration of booster', '6.2.4', 'sessions for mindfulness intervention', 'Modification to educator training', 'Appendix B', 'February 2, 2018', 'Change in eligibility age at diagnosis from', 'Modifications in Sections 1.0, 3.5, 4.1.1,', '<45 years to 50 years or younger at', '7.1.', 'diagnosis', 'May 6, 2019', 'Change in PHQ-8 screening eligibility to', 'Modifications in Sections 4.1.4, 7.2, 7.3,', 'include 3 or greater', '11.0, 18.1.2, 18.2, 18.3, 18.4', 'Revision of sample size estimation', 'Updated details on specimen shipping', 'May 21, 2019', 'Minor accrual clarification', 'Modification in Section 18.2', 'April 10, 2020', 'Changes in collection of T4 data due to', 'Modification in Section 8.4', 'COVID-19 pandemic', 'Minor corrections to questionnaire data', 'Modification section 9.4', 'collection', 'June 22, 2020', 'Control group sessions converted to', 'Modification in Section 8.4', 'remote delivery due to the pandemic', 'Revised Protocol June 22, 2020', 'Page 2 of 50']['Table of Contents', 'SCHEMA', '5', '1.', 'STUDY DESIGN/SUMMARY', '6', '2.', 'OBJECTIVES', '7', '2.1', 'PRIMARY OBJECTIVE', '7', '2.2', 'SECONDARY OBJECTIVES', '7', '3.', 'BACKGROUND', '7', '3.1', 'YOUNGER BREAST CANCER SURVIVORS ARE A VULNERABLE POPULATION', '7', '3.2', 'POTENTIAL INTERVENTIONS TO ADDRESS THE PSYCHOSOCIAL NEEDS OF YOUNGER', 'BREAST CANCER SURVIVORS', '8', '3.3', 'PRELIMINARY DATA', '9', '3.4', 'SURVIVORSHIP EDUCATION (SE) INTERVENTION PROGRAM', '12', '3.5', 'RATIONALE AND SIGNIFICANCE OF THE PLANNED STUDY', '12', '4.', 'PARTICIPANT SELECTION', '13', '4.1', 'INCLUSION CRITERIA', '13', '4.2', 'EXCLUSION CRITERIA', '13', '4.3', 'INCLUSION OF UNDERREPRESENTED POPULATIONS', '13', '5.', 'REGISTRATION PROCEDURES', '14', '5.1', 'GUIDELINES FOR ALL PARTICIPATING INSTITUTIONS', '14', '6.', 'INTERVENTION GROUPS', '14', '6.1', 'PRE-INTERVENTION PREPARATION', '14', '6.2', 'INTERVENTION PROGRAMS', '14', '6.3', 'CONCOMITANT TREATMENTS', '15', '6.4', 'DURATION OF THERAPY AND TIMING OF ASSESSMENTS', '15', '6.5', 'DURATION OF FOLLOW-UP', '15', '6.6', 'CRITERIA FOR REMOVAL FROM STUDY', '15', '6.7', 'DISCONTINUATION OF TREATMENT', '16', '6.8', 'WITHDRAWAL FROM STUDY', '16', '6.9', 'ADDITIONAL INFORMATION', '16', '7.', 'PARTICIPANT RECRUITMENT, ELIGIBILITY SCREENING, AND ENROLLMENT 17', '7.1', 'RECRUITMENT OF YOUNGER BREAST CANCER SURVIVORS', '17', '7.2', 'SCREENING FOR ELIGIBILITY', '17', '7.3', 'FORMATION OF STUDY COHORTS AND PREPARING FOR ENROLLMENT', '17', '7.4', 'ENROLLMENT VISIT', '18', '8.', 'OUTCOME ASSESSMENT', '18', '8.1', 'BASELINE VISIT (T1)', '18', '8.2', 'IMMEDIATE POST-INTERVENTION VISIT (T2)', '18', '8.3', 'INTERVAL FOLLOW-UP QUESTIONNAIRE (T3)', '18', '8.4', 'FINAL FOLLOW-UP VISIT (T4)', '18', '9.', 'OUTCOME MEASUREMENTS: QUESTIONNAIRES AND ANTHROPOMETRIC', 'MEASURES', '19', '9.1', 'BACKGROUND VARIABLES AND POTENTIAL CONFOUNDS', '19', '9.2', 'SELF-REPORTED OUTCOME VARIABLES', '19', '9.3', 'POTENTIAL MODERATORS OF INTERVENTION EFFICACY', '20', '9.4', 'POTENTIAL MEDIATORS OF INTERVENTION EFFICACY', '20', '9.5', 'PROCESS RELATED VARIABLES', '20', 'Revised Protocol June 22, 2020', 'Page 3 of 50']\n\n###\n\n", "completion": "END"}